Evonik Industries announces a global price increase for the product group VESTAMIN® up to nine percent, effective January 1st, 2015. This increase will apply to all orders shipped on or after this date and as contracts allow.
This price adjustment is necessary to ensure that Evonik remains a reliable, quality provider to our customers in a very challenging environment.
Evonik’s Crosslinkers Business Line remains committed to continue the high level of innovation and service that customers have come to expect.
Evonik offers a broad range of products for the coatings, composites and adhesives Industry. Please also visit our website www.evonik.com/crosslinkers for further details.
Evonik, the creative industrial group from Germany, is one of the world leaders
in specialty chemicals. Profitable growth and a sustained increase in the value of the company form the heart of Evonik’s corporate strategy. Its activities focus on the key megatrends health, nutrition, resource efficiency and globalization. Evonik benefits specifically from its innovative prowess and integrated technology platforms.
Evonik is active in over 100 countries around the world. In fiscal 2013 more than 33,500 employees generated sales of around €12.7 billion.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.